Webinar: FDA & the Collapse of Lykos: The Opportunity for Psychedelics

3 months ago

September 4, 2024 | 3:00 PM ET Webinar Healthcare & Life Sciences Team Co-Leader Michael Werner will join a webinar hosted by Bonaventure Equity LLC (BVE) sharing insights on the U.S. Food and Drug Administration’s (FDA) rejection of Lykos’ application for MDMA as a treatment for post-traumatic stress disorder (PTSD). In its decision, the agency cited concerns […]